93 related articles for article (PubMed ID: 32767239)
1. Receptor Tyrosine Kinases in Osteosarcoma: 2019 Update.
Greenfield EM; Collier CD; Getty PJ
Adv Exp Med Biol; 2020; 1258():141-155. PubMed ID: 32767239
[TBL] [Abstract][Full Text] [Related]
2. Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines.
Rettew AN; Young ED; Lev DC; Kleinerman ES; Abdul-Karim FW; Getty PJ; Greenfield EM
Oncogenesis; 2012 Nov; 1(11):e34. PubMed ID: 23552467
[TBL] [Abstract][Full Text] [Related]
3. Receptor tyrosine kinases in osteosarcoma: not just the usual suspects.
Rettew AN; Getty PJ; Greenfield EM
Adv Exp Med Biol; 2014; 804():47-66. PubMed ID: 24924168
[TBL] [Abstract][Full Text] [Related]
4. Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
Tian Z; Niu X; Yao W
Front Oncol; 2020; 10():1642. PubMed ID: 32984034
[TBL] [Abstract][Full Text] [Related]
5. Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro.
Messerschmitt PJ; Rettew AN; Brookover RE; Garcia RM; Getty PJ; Greenfield EM
Clin Orthop Relat Res; 2008 Sep; 466(9):2168-75. PubMed ID: 18607665
[TBL] [Abstract][Full Text] [Related]
6. Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma.
Morioka K; Tanikawa C; Ochi K; Daigo Y; Katagiri T; Kawano H; Kawaguchi H; Myoui A; Yoshikawa H; Naka N; Araki N; Kudawara I; Ieguchi M; Nakamura K; Nakamura Y; Matsuda K
Cancer Sci; 2009 Jul; 100(7):1227-33. PubMed ID: 19486338
[TBL] [Abstract][Full Text] [Related]
7. [Expression analysis of protein tyrosine kinases of the FAK (focal adhesion kinase) family in osteosarcoma].
Schröder A; Delling G; Kaiser EA
Pathologe; 2002 Sep; 23(5):361-6. PubMed ID: 12376862
[TBL] [Abstract][Full Text] [Related]
8. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
[TBL] [Abstract][Full Text] [Related]
10. Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.
Chaiyawat P; Klangjorhor J; Settakorn J; Champattanachai V; Phanphaisarn A; Teeyakasem P; Svasti J; Pruksakorn D
Transl Oncol; 2017 Oct; 10(5):846-853. PubMed ID: 28881260
[TBL] [Abstract][Full Text] [Related]
11. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
[TBL] [Abstract][Full Text] [Related]
12. Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Collier CD; Wirtz EC; Knafler GJ; Morris WZ; Getty PJ; Greenfield EM
Clin Orthop Relat Res; 2018 Jul; 476(7):1400-1411. PubMed ID: 29481344
[TBL] [Abstract][Full Text] [Related]
13. The effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density.
Nikitovic D; Tsatsakis AM; Karamanos NK; Tzanakakis GN
Anticancer Res; 2003; 23(1A):459-64. PubMed ID: 12680249
[TBL] [Abstract][Full Text] [Related]
14. Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis.
Vasilogianni AM; Al-Majdoub ZM; Achour B; Peters SA; Rostami-Hodjegan A; Barber J
Front Oncol; 2023; 13():1010563. PubMed ID: 36890818
[TBL] [Abstract][Full Text] [Related]
15. Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives.
Fleuren ED; Versleijen-Jonkers YM; Boerman OC; van der Graaf WT
Biochim Biophys Acta; 2014 Apr; 1845(2):266-76. PubMed ID: 24582852
[TBL] [Abstract][Full Text] [Related]
16. ROCK1 as a potential therapeutic target in osteosarcoma.
Liu X; Choy E; Hornicek FJ; Yang S; Yang C; Harmon D; Mankin H; Duan Z
J Orthop Res; 2011 Aug; 29(8):1259-66. PubMed ID: 21387396
[TBL] [Abstract][Full Text] [Related]
17. Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer.
Chang J; Wang S; Zhang Z; Liu X; Wu Z; Geng R; Ge X; Dai C; Liu R; Zhang Q; Li W; Li J
Oncotarget; 2015 Feb; 6(4):2009-22. PubMed ID: 25576915
[TBL] [Abstract][Full Text] [Related]
18. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.
Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S
Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412
[TBL] [Abstract][Full Text] [Related]
19. Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.
Esparza-López J; Ramos-Elías PA; Castro-Sánchez A; Rocha-Zavaleta L; Escobar-Arriaga E; Zentella-Dehesa A; León-Rodríguez E; Medina-Franco H; Ibarra-Sánchez Mde J
BMC Cancer; 2016 Sep; 16(1):740. PubMed ID: 27645148
[TBL] [Abstract][Full Text] [Related]
20. Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases.
Brdicka T; Kadlecek TA; Roose JP; Pastuszak AW; Weiss A
Mol Cell Biol; 2005 Jun; 25(12):4924-33. PubMed ID: 15923611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
